Provenance du réseau au premier degré de Paul Aldridge
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO.
23
| Subsidiary | Biotechnology | 23 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Paul Aldridge via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of New Hampshire | College/University | Doctorate Degree Doctorate Degree | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Director/Board Member Founder | |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director/Board Member Private Equity Investor | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Decision Options LLC
 Decision Options LLC Investment ManagersFinance Decision Options LLC is a privately held, SEC-registered investment advisor and hedge fund manager headquartered in Groton, Connecticut. The firm was founded by Gill Eapen in 2001 to initially provide consultation and software for real estate valuation and portfolio management. They expanded the firm’s services to include investment advisory services for individual and institutional clients, thereafter. | Investment Managers | Analyst-Equity Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Masters Business Admin | |
| ERASCA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| The Polycystic Kidney Disease Research Foundation | Corporate Officer/Principal | ||
Stack Diagnostics Nigeria, Ltd.
 Stack Diagnostics Nigeria, Ltd. Medical/Nursing ServicesHealth Services Stack Diagnostics, Inc. provides genetic testing and molecular diagnostics services. It builds first and largest pan-African biobank that helps pharmaceuticals and biotechnology partners study this data set and to identify diagnostic and therapeutic targets that benefit all the people. The company was founded by Abasi Ene-Obong, Gatumi Aliyu, Damilola Oni, and Ogochukwu Francis Osifo in 2019 and is headquartered in San Francisco, CA. | Medical/Nursing Services | Director/Board Member | |
| Rensselaer Polytechnic Institute | College/University | Doctorate Degree | |
| The College of Saint Rose | College/University | Undergraduate Degree | |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Chairman | |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
| SEQLL INC. | Pharmaceuticals: Major | Director/Board Member | |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor | |
Slater Technology Fund, Inc.
 Slater Technology Fund, Inc. Investment ManagersFinance Slater Technology Fund Inc (Slater Technology Fund) is a venture capital firm founded in 1997. The firm is headquartered in Providence, Rhode Island. | Investment Managers | Director/Board Member | |
Proof Diagnostics, Inc.
 Proof Diagnostics, Inc. Medical SpecialtiesHealth Technology Proof Diagnostics, Inc. is a company that specializes in providing affordable and accessible COVID-19 molecular testing using CRISPR technology. The company is based in Cambridge, MA. Led by world-renowned molecular biologist Dr. Feng Zhang, the company aims to help communities take control of their health. Proof Diagnostics was founded in 2020 by Feng Zhang, Sid Shenai, Jonathan Gootenberg, Omar Abudayyeh. Sid Shenai has been the CEO since 2020. | Medical Specialties | President | |
54Gene, Inc.
 54Gene, Inc. BiotechnologyHealth Technology 54Gene, Inc. is an American health technology company that focuses on advancing the field of genomics to improve diagnostic and treatment outcomes for diverse populations. 54Gene is a research, services, and development company located in Nigeria and the United States. The company generates genetic insights from research cohorts in diverse populations to improve the development, availability, and efficacy of therapeutics and diagnostics. The company was founded in 2019 by Dr. Abasi Ene-Obong to improve our understanding of the world's most genetically diverse population. Ron Chiarello has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Ri Bio
 Ri Bio Miscellaneous Commercial ServicesCommercial Services Ri Bio provides life science and biotechnology services. The private company is based in Providence, RI. | Miscellaneous Commercial Services | Director/Board Member | |
ProThera Biologics, Inc.
 ProThera Biologics, Inc. Pharmaceuticals: OtherHealth Technology ProThera Biologics, Inc. develops diagnostics and therapeutics treatments. The firm’s products include replenish the deficiency in patients, significantly reduce inflammation and target the host's dysregulated response. The company was founded by Yow-Pin Lim and Douglas C. Hixson in 2002 and is headquartered in Providence, RI. | Pharmaceuticals: Other | Director/Board Member | |
Claritas Genomics, Inc.
 Claritas Genomics, Inc. Medical/Nursing ServicesHealth Services Part of Harvard University, Claritas Genomics is a CLIA-certified genetic diagnostic testing company based in Cambridge, MA that combines genetic analysis technology with the clinical expertise of pediatric specialists to improve patient care. The company offers a range of services to support clinicians in diagnosing pediatric disorders. Claritas Genomics also provides drug testing services, including the latest innovation in fingerprint drug testing. The company's President and CEO, Patrice Milos, is a pioneer in genomics and medicine. The company's website includes a list of tests available by name and gene. Samples can be sent to Claritas Genomics for processing, and inquiries can be directed to their email or phone number. | Medical/Nursing Services | Chief Executive Officer | |
| Bates College | College/University | Undergraduate Degree | |
Astrocyte Pharmaceuticals, Inc.
 Astrocyte Pharmaceuticals, Inc. BiotechnologyHealth Technology Astrocyte Pharmaceuticals, Inc. operates as a drug development company. The firm focuses on neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company was founded by William S. Korinek and James D. Lechleiter in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Chairman | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| Gordon Research Conferences | Corporate Officer/Principal | ||
Protypia, Inc.
 Protypia, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Inotiv, Inc., Protypia, Inc. provides targeted tissue-based protein and peptide mass spectrometry solutions. The company is based in Nashville, TN. The company was founded in 2017 by Daniel C. Liebler. Daniel C. Liebler has been the CEO since 2017. Protypia was acquired by Inotiv, Inc. on July 07, 2022 for $11 million. | Miscellaneous Commercial Services | Director/Board Member | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member | |
| ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
| Wright State University (Ohio) | College/University | Graduate Degree | |
| Tulane University School of Public Health & Tropical Medicine | College/University | Doctorate Degree | |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Biotechnology | Director/Board Member | |
| IGNYTA INC | Biotechnology | Director/Board Member | |
| Colgate University | College/University | Undergraduate Degree | |
| CARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| Neuropharma Advisors LLC | Corporate Officer/Principal | ||
| CELGENE | Biotechnology | Director/Board Member | |
| ACUMEN PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 50 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 26 |
| Consumer Services | 10 |
| Finance | 7 |
| Commercial Services | 4 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 74 |
| Corporate Officer/Principal | 57 |
| Chief Tech/Sci/R&D Officer | 29 |
| Undergraduate Degree | 20 |
| Doctorate Degree | 20 |
Relations les plus connectées
| Insiders | |
|---|---|
| Claude Bertrand | 20 |
| John LaMattina | 20 |
| Alan Levin | 17 |
| James Bristol | 17 |
| Craig Saxton | 16 |
| Michael Varney | 13 |
| Mostafa Analoui | 13 |
| Patrice Milos | 13 |
| Jeffrey Ives | 13 |
| R. Wayne Frost | 10 |
| Howard L. Foyt | 8 |
| Leigh Bonney | 8 |
| Michael Yeadon | 8 |
| Alan Krasner | 7 |
| Jill Milne | 7 |
- Bourse
- Insiders
- Paul Aldridge
- Connexions Sociétés
